Shanghai Pharmaceutical Company Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Pharmaceutical Company Limited with three other
companies in this sector in China:
China National Accord Medicines Corporation Limited
sales of 41.24 billion Chinese Renmimbi [US$5.99 billion]
of which 75%
China Medicine Health Industry Co Ltd
(25.74 billion Chinese Renmimbi [US$3.74 billion]
of which 67%
was Pharmaceutical Business), and
Jointown Pharmaceutical Group Co Ltd
(61.55 billion Chinese Renmimbi [US$8.94 billion]
of which 97%
During the year ended December of 2016, sales at
Shanghai Pharmaceutical Company Limited were 120.76 billion Chinese Renmimbi (US$17.54 billion).
increase of 14.5%
versus 2015, when the company's sales were 105.52 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shanghai Pharmaceutical Company Limited
(and since 2011, sales have increased a total of 120%).
Sales of Distribution Segment saw an increase
16.3% in 2016, from
90.20 billion Chinese Renmimbi to 104.86 billion Chinese Renmimbi.